Is the FDA About To Eat Their Words on the Safety of Vaccines?

Cervarix, Christina England, Death, Gardasil, Medical Cartel, Top Stories, Vaccine Propaganda

Is the FDA About To Eat Their Words on the Safety of Vaccines?

9 Comments 15 March 2010

.
.
.
.

Christina England
Vactruth.com
3/15/2010

March 12th 2010 saw six very special women from around the world, present documents and research about the HPV vaccines Gardasil and Cervarix to the FDA by request. Never before have the FDA turned to members of the public regarding vaccine safety but in an extraordinary move this is exactly what happened. Dubbed the ‘Little Women’ by the FDA the group presented evidence that will shock the world and could have the FDA eating their words.

The six women who had become increasingly concerned about the HPV vaccines Gardasil and Cervarix presented a power point presentation accompanied with documents showing the dangers of the HPV vaccines to the FDA. Their hope was to prove to the FDA that these two vaccines are so dangerous that they should be removed from the vaccine schedule as soon as possible.

Megan Hild passed away after an adverse reaction to a cervical cancer vaccine.

The women who were involved in this unusual move are Karen Maynor; mother of the late Megan Hild, New Mexico; Rosemary Mathis: mother of Lauren, adversely injured; co-founder of WWW.TRUTHABOUTGARDASIL.ORG, North Carolina; Freda Birrell; political activist,Scotland/UK; Leslie Carol Botha; women’s health educator and broadcast journalist, and founder of Holy Hormones Honey , Colorado; Cynthia Janak: research analyst, journalist writing for Renew America and founder of Only the Truth Illinois; and Janny Stokvis: research analyst, Netherlands.

The reports that were presented, detailed worldwide data, proving that women and young girls have suffered severe adverse reactions, including death, after being vaccinated with the HPV vaccines.

Detailed charts were shown to the FDA clearly outlining evidence of girls from around the world showing very similar adverse reactions after having these vaccines. Only a few of these adverse reactions have ever been listed by either manufacturer on their leaflets. It is my belief that Merck and Glaxo Smith Kline should to study the findings very carefully indeed.

USA – Reports show girls have suffered from

  • Chronic Fatigue

  • Digestive Problems

  • Dizziness and Nausea

  • Encephalitis

  • Facial Paralysis

  • Hair Loss

  • Headaches

  • Joint and Muscle Pain

  • Loss of vision

  • Menstrual Problems

  • Paralysis

  • Rashes/allergies

  • Respiratory and Heart Problems

  • Seizures

  • Syncope

  • Miscellaneous

Spain – Reports show girls have suffered from

  • Chronic Fatigue

  • Dizziness/Nausea

  • Encephalitis/MS/ADEM

  • Facial Paralysis

  • Hair Loss

  • Headaches

  • Joint/Muscle Pains

  • Loss of Vision

  • Menstrual Changes

  • Paralysis

  • Rashes/Allergies

  • Respiratory Heart

  • Seizures

  • Syncope

  • Miscellaneous

Australia – Reports show girls have suffered from

  • Chronic Fatigue

  • Digestive/pancreatitis

  • Dizziness/Nausea

  • Encephalitis/MS/ADEM

  • Hair Loss

  • Headaches

  • Joint/Muscle Pains

  • Loss of Vision

  • Menstrual Changes

  • Paralysis

  • Rashes/Allergies

  • Respiratory Heart

  • Seizures

  • Syncope

  • Miscellaneous

United Kingdom – Reports show girls have suffered from

  • Chronic Fatigue

  • Dizziness and Nausea

  • Encephalitis

  • Headaches

  • Joint and Muscle Pain

  • Paralysis

  • Respiratory and Heart Problems

  • Seizures

  • Syncope

  • Miscellaneous

New Zealand – Reports show that girls have suffered from

  • Chronic Fatigue

  • Digestive Problems

  • Facial Paralysis

  • Headaches

  • Joint and Muscle Pain

  • Paralysis

  • Rashes/allergies

  • Respiratory and Heart Problems

  • Miscellaneous

There is a clear pattern from many countries, of girls suffering from the same side effects and yet up to now this fact has not been picked up, by either the committees who regulate our vaccines, or the Governments who sanction them. More worryingly the six women found that there were a huge number of deaths recorded on VAERS after HPV vaccines.

VAERS is the reporting system used in the USA for adverse events that happen after vaccination.

Strangely however, the system does not appear to be examined in great detail by the either Big Pharma or the Government and many adverse events are not even recorded at all, as it has now been discovered that some doctors are completely unaware of it’s existence.

The six women involved in the presentation to the FDA have been able to show research papers from top scientists and researchers showing that blindness can occur after the HPV vaccine . Papers on Menstrual evaluation were also seen for the first time as were papers on Vaccine and Autoimmune problems.

Janny Stokvis one of the women who researched the side effects of these vaccines after watching a YouTube clip said that she was horrified that so little has been done to protect women. She said she became involved completely by chance.

In September 2008 I was looking for music on Youtube and I ended up watching a video the father of Brooke Petkevicius made. Brooke died 14 days after her first dose of Gardasil from a pulmonary embolism or blood clot on March 26th, 2007. I was shocked by her story. In our family we have a rare blood clotting disease. I have had a pulmonary embolism twice myself. Few weeks later I saw a Dutch documentary about the marketing tactics of Merck. that alarmed me even more. My daughter was in the age group to get the HPV vaccine so I started to do my own research.”

She has since studied the VAERS reporting system and now firmly believes that the reporting system is only the tip of the iceberg because it only has a small number of the actual side effects from these vaccines on. She was shocked to learn that many of the doctors she spoke to had not heard of the reporting system and said :-

Adverse reactions do not always start within a minute after inoculation like some people think. A lot of physicians have never heard of VAERS or know how to file a report. I was surprised when I heard this the first time. Physicians do not agree with parents when they tell that they think theirs daughter got sick because of the HPV vaccine and do not want to file a report.Mothers who find their way to the Gardasil groups did not always succeed in getting a report filed at VAERS.

HPV-vaccine victims can be very ill, but tests can show-up to be normal. Girls who have seizures several times a day or who are paralysed get diagnosed as “Psychogenic”.

Parents are often told the illness of their daughter is not vaccine related This has to change, because too many girls are not getting the proper treatment yet.”

She said up until she looked into the HPV vaccines she had always believed in the Governments vaccine programmes but her confidence has now been badly shaken.

Rosemary Mathis whose daughter was changed after she had Gardasil vaccine and one of the six women told me she became involved with the group because she wanted answers. She says:-

My 12 year old daughter was disabled by Gardasil.  Her life as she knew it completely changed after her third vaccination.  She could no longer attend school, go to church, or live a normal life.  She was always in pain and we spent thousands of dollars and many hours going to doctors who could not help her. I spent countless hours on the internet researching how to treat my daughter. I quickly learned that I was not alone and many other parents were doing the same thing. Every night was spent researching trying to figure out what do to not only help my daughter, but many others. This led me to Gardasil Mom groups on Yahoo Groups, Twitter, and Facebook. That is where I met Marian Greene, another mother whose girl was affected that lives about 30 minutes from me. Her daughter was disabled also. Both our daughters were disabled by the exact same lot # 0067X.Night after night, we were trying to help the mothers figure out what to do and trying to comment on stories on the internet to warn others. We quickly learned that many of the girls stories are not recorded in VAERS. Either the parents do not know about VAERS and haven’t reported them or the doctors do not. I filed my daughter’s report in VAERS and then asked my doctor to after continuously expressing that the vaccine is what made her sick. The parents were struggling to find a way to express their stories and to find data. Each night, new victims were appearing on the boards with no idea of what to do.

That is when we decided to created WWW.TRUTHABOUTGARDASIL.ORG. The board represents the TRUTH as we the parents of the victims of Gardasil see it. It is a central repository used to house the girls stories for view by others, has the latest news, and has a Guardian Angel page by location to give the parents contacts in their area who may be able to help them. It has videos, other site links, a forum so you can talk to other parents/victims, etc. It has made it easier for parents to quickly identify side effects, treatments that may have helped victims, etc. It takes about one year worth of research off the parents and allows them to quickly identify what occurred and what can be done to help the victims.”

Since her research began Rosemary says she has met thousands of girls who have been adversely affected by the Gardasil and the Cervarix vaccines.

I asked Leslie Botha how the FDA had become aware of the six women and had asked the group to do the presentation.

Leslie said that originally Karen Maynor had contacted the FDA after her daughter had died after she had the Gardasil vaccine. Her letter to Dr Margaret Hamberg MD contained many reports and details of young girls who have either died like her daughter Megan, or had become seriously ill.

The reports contained in her letter do not make comfortable reading. She wrote how one child ‘Samantha Hendrix’ who had once been described as a ‘walking encyclopaedia’ has been left with no concentration and failing her exams.

Also In the case of young Samantha, she had a serious history of illnesses prior to vaccination, have you ever discovered if Merck carried out research on impaired immune responsiveness to establish if young girls with a medical history would be well enough to have this vaccine? In the case of Cervarix, GlaxoSmithKline did not carry out this research prior to the commencement of the vaccination programme in the United Kingdom. This young girl had many health problems before being vaccinated but now she is far worse off and what the future holds for her we just do not know. Perhaps, if more care and attention had been given by the pharmaceutical company in all of this, if they had taken more time to carry out the research into all aspects of safety and just had given it a few more years, exactly the same advice that Dr Harper gave to the UK regarding Cervarix, then perhaps these young ladies would not be so ill and I would not be writing to you today to ask for your help. With respect to Cervarix, many of the same “Gardasil” illnesses are occurring in the United Kingdom also so there appears to be a common thread that exists between these two HPV vaccines.”

She wrote.

She has a point, as on the Glaxo Smith Kline original GP advert it does state that ‘there are no data in the use of Cervarix in subjects with impaired immune responsiveness’.

Leslie said that the FDA do not just contact people but that they respond to letters. They contacted Karen and Karen knowing that she could not do what the FDA wanted alone asked the other women if they were prepared to help her.

Leslie says:-

The first meeting conference call was in September/October with Cynthia, Freda, Rosemary and myself – where we expressed our concerns.

There was a second Webinar in November that the FDA presented for us on how their organization operates.

It was at this meeting that a third meeting was initiated – to be held at first before the holidays so that we could present research and data that backed up our concerns.

It was at this point that we asked Janny to join us since she spent so much time going through the VAERS reports.

By agreement, the meeting was pushed back until after the holidays – until the presentation.

We were in discussion many times about how to proceed – and found the people in the Patient Representative Program Office of Special Health Issues - to be open, and supportive as they shared the guidelines for the presentation.

The FDA has just initiated “listening sessions” and our group was one of the first to participate in them.

It has been an honor and a very positive experience from beginning to end.

We started out by gathering data, Rosemary, Freda and Janny did a fabulous job of creating and presenting graphs, and outlines of VAERs deaths.Freda was in contact with women in Spain, New Zealand and Australia as she gathered reports of adverse injuries from the girls in these countries.

Cynthia and I kept coming from different angles on what was causing the problem with this vaccine – mine was on menstrual cycle influence and she was focused on histamine and IgE.  We spent hours on the phone searching for studies.We would then do searches on histamine and IgE and the menstrual cycle and that is when we realized that our differing angles were beginning to blend into one perfect storm. It was the peer reviewed study that came out on the blind girl and HPV that nailed this for us – and we realized that we had discovered the REAL DANGERS with this vaccine.

We were shocked and awed that we had come across something no on had ever considered that founded both of our concerns.”

The conclusion slide 52 in the powerpoint shows exactly what was discovered and one has to agree the implications this has on many girls is quite shocking.

During the follicular phase of the menstrual cycle, the production of estrogen releases histamine. During the luteal phase the protective effects of estradiol sharply decline, the production of progesterone increases and the immune system becomes more easily compromised; succumbing to the overdose of histamine from three sources: L-Histidine in the vaccine, increased amounts of estradiol in the body from natural production plus environmental toxins (estrogen mimickers) and the body’s own natural production of histamine. The rise and decline in hormones; the rise and decline in immunity and the overproduction of histamine – may be a factor as to why the health of the girls adversely affected by the HPV vaccines is not improving.

Both HPV vaccines are VLP’s (virus like particles). This can be termed ‘molecular mimicry’ and when an antigen in a vaccine is structurally similar to an antigen in the host antibodies are produced that react with the host’s normal tissue.

Allergy sufferers with moderate to severe asthma have IgE levels greater than 1,000 U/ml.


Normal serum IgE levels in individuals without allergies is less than 70 U/ml. An increase in IgE means more free IgE is available for binding to the activated mast cells. More mast cell activation and degranulation may lead to an increased release of inflammatory histamine. This reaction also leads to TH2 cytokine and leukotriene secretion, resulting in systemic anaphylaxis in the form of allergy.

This proves an increased risk of injury due to an overload of histamine being released from the mast cells causing a more severe inflammatory response throughout the body. Tissue damage due to this process can cause hypertrophy of smooth muscles. Smooth muscles are evident in the heart. With the rechallenge to an already active immune response we could have more smooth muscle damage especially to the heart and damage to the Central Nervous System.

With all our research completed, due to the lack of safety testing in regards to hormone, histamine and IgE level effects due to challenge and rechallenge on the female and male physiology the risks of the HPV vaccines outweigh the benefits.”

To learn exactly how this conclusion was reached read the full powerpoint presentation and documents

Freda Birrell another member of the group became involved in 2009, when her friend wrote to her asking for her help, saying that her daughter Bridget had become injured after the Gardasil vaccine.

Freda said that she asked me to find out if Cervarix was having the same effect on British girls as the Gardasil vaccine. After research I found that both vaccines were having serious adverse reactions.

Freda feels disillusioned with the British and Scottish Governments she said:-

Both of the Health Ministers are too ready to come back with the usual information – any incidents which have occurred are either coincidental or part of population related illnesses.  At no time, to my knowledge or satisfaction, do they investigate any of these illnesses.  There are serious cases of arthralgia after vaccination with Cervarix and this condition has been researched and it is known that it is and can be vaccine related.  Sadly, our Ministers do not wish to recognise that fact.  There are many other serious illnesses which have occurred, eg a rare form of encephalitis, paralysis, blindness, seizures to name but a few. They are hiding their heads in the sand in the hope that it will all go away.  That will never happen where the lives of our young girls are involved.”

I asked Freda as she had studied both vaccines in detail if she felt that Cervarix was as dangerous as Gardasil. She said:-

For the most part Cervarix elicits a much higher percentage of adverse events in the initial days after inoculation over Gardasil.  The comparison suggests that Cervarix is much less safe than Gardasil.  High percentages of fatigue, headache and myalgia may also be initially construed as the flu and not Cervarix related and therefore would not be reported as an adverse event related to the vaccination until the symtpoms persist past the one week time frame for the flu,  Gardasil has incurred many deaths.  Only one girl to our knowledge has died following a Cervarix vaccination and her case was attributed to her underlying illness, cancer.  She was undergoing tests apparently at the time.  Whilst we cannot say that Cervarix caused her death, the authorities likewise cannot say with 100% proof that it didnt.  What we can say with 200% certainty is she should not have been vaccinated whilst undergoing medical testing”

Also discovered by the group was the fact that neither vaccine worked if the girls already had an HPV infection.

Slide 15 states:-

Conclusions: Evidence detailed here regarding the poor efficacy of both Gardasil and Cervarix on already infected women has to be investigated further. If this is occurring in established infected groups of women then what will be occurring in the bodies of adolescent girl’s who in many cases may already be sexually active and be infected at the time of vaccination? In the United States and United Kingdom, HPV SCREENING DOES NOT TAKE PLACE TO DETERMINE IF HPV INFECTION IS ALREADY PRESENT.”

The group had discovered that contrary to belief HPV is not only a STD but can be transmitted through other means. This was discussed on slide 9.

The next series of slides will address whether HPV is transmitted solely via sexual contact”.

Slide 9

In the first research paper there is growing evidence that HPV infection is acquired through non-sexual routes and that one potential route is mother-to-child transmission in the perinatal period; referenced as vertical transmission.

In the second paper, it was noted that HPVs have been detected in virgins, infants/children, and juvenile Laryngeal papillomatosis was shown to be caused by these viruses. It has been acknowledged that HPVs may be transmitted by other non-sexual routes as well.”

Another very important point raised was the fact that over 250 girls who have had the vaccine have since had abnormal PAP Smear tests. This was thought to be because this group already had the HPV virus when they had the vaccine.

We now await the FDA’s verdict on the impressive array of documents and factual information that this group of so called ‘little women’ put before them. Will the FDA acknowledge that far from the wonder vaccines that Gardasil and Cervarix were supposed to be, these vaccines were more like poison darts thrown at girls in a crucial stages of their sexual development? These vaccines were given to young girls in many different stages of puberty and at many different stages of their menstrual cycles. We are now left wondering if the manufacturers Merck and Glaxo Smith Kline ever even considered this when developing these vaccines.

I will finish with a dedication to Megan from the very special mother Karen Maynor who wrote to the FDA and started this whole series of amazing events.

She writes:-

Megan

As I stand here and watch as your brother receives his award for Academic Excellence I cannot help but think of you now and how proud I know you would have been. It was hard for him Megan as he hurts so much because you are not here. When we come together as a family for these occasions it never feels right. We miss you so…………………

We are working hard for you babe to get this information out there so others will know what can happen with this vaccine. Help others to become informed. To keep other moms and dads from having to feel this pain.

There are so many now that are fighting for ones just like you and for the many that are injured. You should see them, facing the GIANTS of the FDA and Big Pharma with no fear. They are strong because they have the truth. They never got to know you but they are fighting for you.

We love you and miss you……………………………………..”

Share and Enjoy:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • StumbleUpon
  • Twitter
  • Yahoo! Buzz
  • PDF
  • LinkedIn
  • Live
  • NewsVine
Merck to Build New Vaccine Plant With IBM, GM, UPMC and Battelle

Medical Cartel, Top Stories, Vaccine Development

Merck to Build New Vaccine Plant With IBM, GM, UPMC and Battelle

No Comments 11 March 2010

Press Release

CONTACT: Wendy Zellner
PHONE: (412) 586-9777
E-MAIL: ZellnerWL@upmc.edu
Battelle, IBM, Merck Join UPMC’s Effort to Produce Vaccines to
Protect Public Health
21st Century Biodefense Offers Innovative Solution to President Obama’s Call for
Improved Response to Bioterrorism and Infectious Diseases

PITTSBURGH, March 11 – Building on its extensive efforts to establish a flexible vaccine development and production facility to strengthen the nation’s biosecurity, UPMC announced today that it has been joined by Battelle, IBM and Merck & Co. Inc. in this first-of-its-kind initiative. These industry and non-profit leaders are supporting UPMC and GE Healthcare in pursuing the construction of this facility, which UPMC proposes to operate in a unique partnership with the federal government.

“With this powerful coalition of partners, we will finally address a critical gap in the nation’s defenses against bioterrorism and infectious diseases,” said Robert J. Cindrich, UPMC’s chief legal counsel and chairman of the initiative, known as 21st Century Biodefense (21CB). “Through this collaboration, we are poised to deliver the urgently needed advances in vaccine development and manufacturing as recently called for by President Obama in his State of the Union address.”

Battelle, the world’s largest, independent research and development organization, has agreed to provide comprehensive pre-clinical research and development services, including infectious disease model development and product safety and efficacy evaluations in a Good Laboratory Practice (GLP) environment. These services will support the licensure of new vaccines and therapeutics by the U.S. Food and Drug Administration. Battelle also will provide project management support and senior leadership to 21CB’s advisory board. “We are committed to solving the most critical problems in human health and stand ready to be a full partner in this impressive public-private initiative,” said John Wade, vice president for Battelle.

IBM will provide innovative information technology, such as IBM’s new POWER7 systems, to create the infrastructure that will support 21CB manufacturing processes and operations. This infrastructure will be able to handle extreme volumes of data and scale quickly to adapt to changing demand. “IBM brings leading technology to 21CB, as well as access to teams of life sciences researchers at each of our eight research labs around the world,” said Dan Pelino, general manager, IBM Healthcare and Life Sciences. “We’re pleased to bring our deep skills and pharmaceutical industry consulting expertise to support 21CB and its important mission.”

Merck, a global pharmaceutical company, has agreed to provide drug-development and bioprocess counsel as part of a planned consortium of other biopharmaceutical companies. Merck also will provide senior leadership to 21CB’s advisory board and training for facility staff when 21CB begins operations. “As a global company with a long history of dedication to public health, Merck is pleased to share its technical expertise with 21CB in this innovative approach to enhancing our nation’s biodefense capabilities,” said Diana Lanchoney, executive director, Merck Research Laboratories. These new 21CB partners join GE Healthcare, which announced in October 2009 that it would provide manufacturing design and development expertise, as well as production equipment, consumables, and manufacturing processes for 21CB. GE Healthcare’s leadership in bioprocessing and its innovative disposable manufacturing technologies will enable 21CB to rapidly and flexibly produce vaccines for the U.S. government’s dynamic biosecurity needs. The new facility would be designed to produce multiple vaccines simultaneously and would have the ability to quickly switch production from one vaccine to another to respond in a crisis.

In his State of the Union address on Jan. 27, President Obama announced a new initiative to respond faster and more effectively to bioterrorism and infectious diseases. The Administration said it plans to pursue “a business model that leverages market forces and reduces risk to attract pharmaceutical and biotechnology industry collaboration with the U.S. government.” Department of Health and Human Services Secretary Kathleen Sebelius has launched a comprehensive review of the nation’s public health countermeasure enterprise with the goal of providing “a modernized countermeasure production process where we have more promising discoveries, more advanced development, more robust manufacturing, better stockpiling, and more advanced distribution practices. In other words, we want to create a system that can respond to any threat at any time.”

With the expectation that the government will allocate money for this public health priority, UPMC and its partners plan to compete for the funds to build a vaccine facility. Through 21CB, UPMC would share in the necessary private funding and own and operate the facility under the direction of the federal government as a public-private partnership, thus ensuring that the plant focuses on national health priorities. The initiative would create 1,000 jobs directly and up to 6,000 indirectly, while increasing the nation’s pool of scientists and engineers.
# # #
About 21st Century Biodefense (21CB) 21CB is a non-profit corporation established by UPMC in 2009 to build, own and operate a facility for the development and manufacture of biologic drugs and vaccines to protect against bioterrorism and certain naturally occurring disease threats. The targeted drugs and vaccines have limited commercial markets, thus spawning the need for this new and innovative solution. 21CB has created a coalition of private interests to work with the U.S. government in helping it meet its responsibilities in the area of biodefense. 21CB would act in a public-private partnership with the U.S. government to bring to bear the expertise and resources necessary to meet the nation’s pressing need for medical countermeasures and therapeutics to combat bioterrorism, while fortifying and expanding the nation’s bio-industrial base.

Share and Enjoy:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • StumbleUpon
  • Twitter
  • Yahoo! Buzz
  • PDF
  • LinkedIn
  • Live
  • NewsVine
Vaccine Teams Dispatched to Inject the Unsuspecting

Medical Cartel, Top Stories, Undue Influence

Vaccine Teams Dispatched to Inject the Unsuspecting

No Comments 01 March 2010

.
.
.

Seeing POD People? It’s No Sci-Fi Film

By ARIEL KAMINER
NYTimes
3/1/10

PODs are the sleeper cells of public health, assuming a different shape and observing different local mores each time a crisis emerges. When hepatitis A was diagnosed in a bartender at the Manhattan nightclub Socialista two years ago, POD people were on hand to vaccinate patrons, including some guests at Ashton Kutcher’s birthday party. In the case of a bioterrorism attack, they might turn up in your neighborhood dispensing anthrax antidote. On Feb. 18, they were in Anshe Sfard Hall in the Borough Park section of Brooklyn, rolling up the sleeves of Hasidic Jews. That’s a long way from Ashton Kutcher.

I entered the hall on the left, with the other women; men entered on the right. With stacks of gold-braided chairs in the corner and a divider to keep the sexes apart, the Anshe Sfard POD — short for Point of Distribution — could have been the day-before photo of an Orthodox wedding. Instead, it was the front line against one of the city’s more surprising outbreaks in years.

It started last year, when some children at a Jewish summer camp in the Catskills came down with mumps, one of those childhood diseases that were supposed to have been consigned to history. They brought it back home to the Hasidic enclaves in Borough Park, Crown Heights and Williamsburg. By last month, there were more than 900 cases, and more adults were getting sick.

Time to activate the PODs.

Mumps is not generally fatal, though it is painful and can cause deafness or infertility. In neighborhoods where families might have a dozen children, and young men spend long days together in yeshivas or synagogues, it spreads fast. But business was slow at Anshe Sfard, so Sheila Palevsky and Elissa Levine, two of the sharp, funny members of the POD team, were keeping each other amused with tales of former postings.

Hasidic Jews may be more inclined to visit their own doctors than to discuss bodily functions with strangers. (“When did you last go to the mikvah?” Ms. Levine asked while taking my medical history, referring to the ritual bath that many observant Jewish women visit after menstruating. I thought the euphemism was very sweet.) As for the antivaccine movement, its echoes are rare in these parts, but they ring out with a strong local accent. “Jews trust the Almighty, not vaccines,” one commenter wrote on the site of The Yeshiva World, an online newspaper, in a mix of Hebrew and English. On a Crown Heights Web site, someone else wrote, “I wish that folks would have as much faith and confidence in God as they do in doctors and scientists.”

But there is another reason things look different here: This outbreak has written a new chapter in epidemiological history.

The standard prescription is two doses of the M.M.R. (measles, mumps, rubella) vaccine in childhood. That’s what most of the patients in Brooklyn had gotten, and it didn’t help them. Which has led medical professionals to reconsider some long-held notions about mumps in particular and communicable diseases in general.

“People that have measurable antibodies to mumps, which I was always taught meant you were immune, we found are getting the disease,” said Dr. Edward Chapnick, director of infectious diseases at Maimonides Medical Center. “And two vaccines, which we always thought had a very high effectiveness at preventing this, turns out to have a 75 to 80 percent effectiveness.”

The Department of Health still recommends two shots, but many doctors in the area — including Dr. Eli Rosen, a pediatrician who said he had treated 200 to 300 mumps cases so far — now favor three vaccinations, as do other private doctors in the area. “It appears that two vaccines are not effective in the vast majority of cases,” Dr. Rosen said. “Is this going to be a pattern we’ll see as we go out in vaccine years?” And, he added, would other vaccines also lose their effectiveness over time?

As a child I probably got my two M.M.R. shots, but who remembers. Everyone I spoke to assured me that so long as I wasn’t pregnant and did not have an immune disorder, there was no downside to an extra shot. But what’s the chance I would really need it? I don’t hang out in Brooklyn yeshivas.

In a city where people live so close to one another, it’s baffling that an outbreak could stay confined to a specific population, even an insular population. But that’s the paradox of city life, on an epidemiological scale: We are simultaneously a teeming megalopolis and a collection of little villages (or offices or apartment buildings), each with its own public health profile.

Still, a cluster of cases has already been documented in Orthodox and Hasidic neighborhoods of Westchester County. Unless that outbreak is halted, entropy will eventually win out.

So at the Quality Health Center in Williamsburg, which has reported hundreds of suspected cases, I decided to roll my sleeve up. Turns out it’s not just a fear of needles that makes little kids cry; the shot really did smart.

To distract me, Dov Landa, a physician assistant, shared the story of a 40-year-old Hasidic woman who had brought her large family in the day before. When it was her turn to get vaccinated, Mr. Landa, following protocol, asked if she was pregnant. The woman laughed. “I haven’t been pregnant in 10 years,” she said. He tested her anyway, just to be sure. And so it was that he got to tell her the happy news. Mazel tov.

Share and Enjoy:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • StumbleUpon
  • Twitter
  • Yahoo! Buzz
  • PDF
  • LinkedIn
  • Live
  • NewsVine
Doctor Fired After Warning Colleagues of H1N1 Vaccine Dangers

H1N1, Medical Cartel

Doctor Fired After Warning Colleagues of H1N1 Vaccine Dangers

No Comments 24 February 2010

Share and Enjoy:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • StumbleUpon
  • Twitter
  • Yahoo! Buzz
  • PDF
  • LinkedIn
  • Live
  • NewsVine
The British Government refuse to compensate health workers who become ill after conditional vaccines

Hepatitis B, Medical Cartel, Top Stories

The British Government refuse to compensate health workers who become ill after conditional vaccines

No Comments 12 January 2010

.
.
.

Christina England
American Chronicle
1/11/2010

Yesterday a story broke in Great Britain where hundreds of front line workers had had routine vaccines as a condition of employment and had become vaccine damaged as a result. These workers, which included doctors, nurses, firefighters, prison officers, forensic scientists and binmen received vaccinations as a condition of employment and have since become ill. Once ill and leaving them effectively unable to perform the job the had trained for and loved they have been abandoned by the ever so caring British Government.

Lucy Johnston -Fury at Vaccine Scandal from the Express took up their story.

“Up to 200 doctors, nurses, firefighters, prison officers, police officers, forensic scientists and binmen say they have developed serious physical and mental health problems after injections essential for their work over the past 10 years. All have given up their jobs and some are up to 60 per cent disabled.”

The British Government should hang their heads in shame. Although these workers were not forced to have these vaccinations they did face losing their jobs if they didn’t receive them. These men and women put their lives in danger to keep Great Britain safe, they make life and death decisions and face some of the most dangerous situations known to man. This is how their Government treats them.

Lucy writes;-

“Frontline health workers, social workers. prison officers and binmen have to be vaccinated against Hepatitis B as a condition of their employment.

This is to protect them from contracting potentially fatal conditions from infected blood through needle injuries and physical assaults.

Although they are not legally forced to have the vaccinations, without them they are not allowed to work.”

This sounds like they are forced to me.

The conditions that these workers now have as a result of the vaccinations are reported to be , chronic fatigue, muscle pain and cognitive problems. These are problems that many experts say are associated with adverse reactions to vaccines.

Dr Charles Shepherd in his letter to the BMJ – Hepatitis B vaccination and Chronic Fatigue Syndrome says:-

“I wish to report some preliminary findings on a cohort of 91 CFS patients where the outset or a significant degree of relapse appears to have been associated with vaccination. Of particular interest is the fact that 50% (54/91) of these cases involve vaccination against hepatitis B”

His letter makes interesting reading especially the part that that states;-

“Of concern is the fact that (a) several health workers reported that they were persuaded to continue with their vaccination course despite the fact that they did not appear to be fully recovered from an adverse reaction (eg general malaise) following the first or second dose, (b) very few of these adverse reactions have been reported to the Committee on Safety of Medicines and (c) the manufacturers acknowledge that individual adverse reactions can include fatigue, myalgia, arthralgia, headache, insomnia and lymphadenopathy but refuse to accept that any causal link has been established with a combination of the above (ie CFS).”

He is not alone in his findings.

Dr Byron Hyde – testimony before the Quebec College of Physicians Medical Board

Hepatitis B vaccination and Chronic Fatigue Syndrome

“We looked at hep B immunisation in Quebec province because one nurse phoned us saying she had CFS after having hep B immunization…..About a month later the same nurse called again, she now had 5 other nurses in the area who had fallen ill with CFS-like symptoms after the vaccine, all were unable to return to work. I told her to phone the maker, Merck. She told me she did and they said the 6 nurses were the only persons in the whole world that had ever had a serious side effect and therefore there couldn’t possibly be a link. And, they told her that she was the only person who had ever phoned….she said that when her doctor phoned, he too was told he was the only person in the world that had ever called, and when each of the doctors of the other nurses called in, each was told the same thing”

One nurse explains how the Hep B vaccine she was required to have stole two years of her life in her response to an article in the BMJ.

Hep B vaccine stole two years of my life

Dawn C Etchell,

occupational health adviser

imperial Buildings Rotherham,

S60 1PA

“I was working as a dialysis nurse and attended for my first ever Hepatitis B vaccine without any worries. The following day I felt unusually tired. The tiredness gradually became totally out of charcter for me and gathered momentum over the following week. I even fell asleep during a routine filling at the dentist. Finally, I had a seizure one morning in the shower and had to call out my General Practitioner. I was unable to get out of bed for the next two weeks and slept for around 18 hours of every day for the next four weeks. If I tried to ‘come round’ my legs would give way and the feeling of pressure in my spine and head were frightening. My vision was constantly blurred and hard to understand. My thyroid was painful and swollen and I had palpitations that were disabling. Electric like shocks in my arms and legs were acute and came without warning. My brain was ‘foggy’ and Ifelt was living in a dreamlike state most of the time. I had difficulty finding words and my speech was slurred. I was referred to a neurologist – brain scan normal – blood tests normal except for raised Anti-Nuclear Antibodies initially – EEG normal – TSH 0.5 – T4 15 (3 months later TSH 0.46) Diagnosis – reactive seizure. All of my symptoms were pointing to a tentative diagnosis of Myalgic Encapelopathy/Chronic Fatigue Syndrome. This I rejected after some six months and am now under annual review for thyroid blood tests. My health suffered greatly and it has taken two years to return to 80% of my previous health status. I never did receive a definite diagnosis and have had to resign myself to the fact that ‘this is as good as it gets’. I, of course, never returned for the full course of hep B vaccines and decided to leave dialysis and return to Occupational health – with a totally different view of administering such ‘preventative’ vaccines! I refused the lumbar puncture as this was offered at a time when I could feel some improvement in my general health and I did not want any further decline at this point. This vaccine should come with a very strict warning and anyone who administers the Hep B vaccine should have ALL the facts at their disposal. I was totally unaware of the dangers before I had the vaccine but found hundreds of cases similar and worse than my own after the event.

Competing interests: None declared”

Around the world Governments are putting the very people they rely on in a crisis in danger, by using emotional blackmail to force them to have vaccines. The very least they can do is when these people suffer adverse reactions is to compensate them for their injuries. After all they keep saying the vaccines are safe, perhaps they are worried that compensation may prove that they are not.

Share and Enjoy:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • StumbleUpon
  • Twitter
  • Yahoo! Buzz
  • PDF
  • LinkedIn
  • Live
  • NewsVine
Big Pharma Planning to Fund Hollywood Production

Medical Cartel, Top Stories

Big Pharma Planning to Fund Hollywood Production

No Comments 07 January 2010

Diet Drug Maker Glaxo to Pay for a Film on Eating
By BROOKS BARNES
NYTimes.com
January 7, 2010
LOS ANGELES — GlaxoSmithKline is getting into the movie business, pursuing an unusual and most likely controversial strategy to increase interest in a weight-loss drug.

Glaxo, the pharmaceutical giant behind Alli, an over-the-counter weight-loss product, has decided that a good way to educate Americans about obesity — and increase sales of Alli — is to finance a “hard-hitting” documentary about eating.

Although a budget has not been set, an Academy Award-winning director will be named on Jan. 25 at the Sundance Film Festival, a spokesman for Glaxo said.

To lend credibility to the project, Glaxo sought out a partner: the Creative Coalition, a nonprofit social and political advocacy organization backed by prominent entertainers like Alec Baldwin, Tim Daly and Susan Sarandon. The organization has decided to produce the film with Glaxo, aiming to deliver a finished picture this year. Although theatrical distribution is a goal, distribution plans are incomplete.

“This won’t be a marketing tool at all,” said Robin Bronk, the Creative Coalition’s executive director, adding that working with Glaxo on the project is “a natural progression of our mission to develop educational projects.”

The organization has a track record. Showtime bought its most recent documentary, “PoliWood,” a look at politically active actors during the 2008 Republican and Democratic conventions that was directed by Barry Levinson, who made “Rain Man.” Ms. Bronk and Rachel Ferdinando, a Glaxo marketing executive, said there would be a signed agreement giving full creative control to the director and the Creative Coalition team. Ms. Ferdinando said Glaxo had no expectations that Alli, which blocks some fat from being absorbed into the body and can result in unpredictable flatulence and diarrhea, would be mentioned in the documentary.

“The filmmakers can make a decision about whether Alli is important,” she said. “We want it to be entirely transparent; we want it to have integrity. It’s a fantastic outcome if people are simply more educated.”

Even so, Glaxo’s financial backing is sure to raise eyebrows. While corporations back films all the time, it is rare for one to pay for a documentary with direct hopes that it will translate into bigger profits. As a rule, documentary makers are an aggressively anticorporate crowd.

“I’m skeptical that this won’t be an infomercial disguised as an independent documentary,” said Theodore Braun, the director of the 2007 film “Darfur Now” and an associate professor at the University of Southern California’s School of Cinematic Arts. “I can’t imagine that a company as legally and rhetorically sophisticated as GlaxoSmithKline is going to leave its interests unprotected.”

Other analysts of the documentary art form said that the film project should not be judged too hastily.

“Because we are in this era of strategic social media, we can’t think of this in that old way we used to,” said Pat Aufderheide, director of the Center for Social Media at American University. “If Glaxo signs an agreement saying that we will pay for it but we won’t look at a rough cut, then I think you have a case where this effort could have some real value.”

Neither Glaxo or the Creative Coalition would discuss a budget for the film, saying that would depend on negotiations with the director, among other factors. Ms. Ferdinando said Glaxo was investing “substantial resources” in the film and that the budget was “expected to be consistent with other documentary projects of a similar nature.”

The partners say they hope to emulate “An Inconvenient Truth,” Al Gore’s celebrated 2006 documentary on climate change. It cost an estimated $1.5 million to produce and sold $50 million in tickets worldwide. Ms. Ferdinando summarized the film as “the ‘Inconvenient Truth’ of mindless eating,” with the story taking a “behind-closed-doors, fly-on-the-wall” approach that highlights unhealthy relationships people have with food.

“This represents a new initiative for us as a company, to take a serious issue and make it more understandable to people,” Ms. Ferdinando said.

As part of the partnership, the Creative Coalition will organize a panel discussion at Sundance to promote Glaxo’s recent study findings about eating habits and talk about ways for the entertainment industry to get more involved in reducing obesity. Panelists will include Jeff Garlin of “Curb Your Enthusiasm,” Ricki Lake and Emme, the plus-size model

Share and Enjoy:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • StumbleUpon
  • Twitter
  • Yahoo! Buzz
  • PDF
  • LinkedIn
  • Live
  • NewsVine
More Propaganda to Sell Vaccines: Swine flu virus ‘could still mutate’ WHO warns

H1N1, H5N1, Medical Cartel, Top Stories

More Propaganda to Sell Vaccines: Swine flu virus ‘could still mutate’ WHO warns

2 Comments 02 January 2010

.
.
.

BBC
December 29th, 2009

The head of the World Health Organisation (WHO) has warned the global swine flu pandemic is not yet over and the virus could still mutate.

Dr Margaret Chan said it was important to “guard against complacency” despite signs the disease had peaked in North America and parts of Europe. She said the virus was still active in countries including India and Egypt. More than 11,500 people are believed to have died in more than 200 countries and territories because of swine flu.

However Dr Chan said it would take at least two years before a true death toll could be established. The WHO’s director general said the US, Canada and the UK were among those countries where the worst of the swine flu outbreak had appeared to have passed.

Danger

But she added: “It is too premature and too early for us to say we have come to an end of the pandemic influenza worldwide.”
She said experts needed to continue monitoring the pandemic for another six to 12 months as it could mutate into a more dangerous strain. “We will watch this virus with eagle’s eyes,” she said. Dr Chan said it was fortunate the pandemic had been milder than expected.

“The fact that the long overdue influenza pandemic is so moderate in its impact is probably the best health news in a decade,” she said.

Millions of people are believed to have recovered after contracting the virus and displaying few symptoms. She said the demand for swine flu vaccinations in some European countries had been lower than expected and WHO was investigating whether superfluous vaccines could be sent to developing countries.

Dr Chan said drug makers and countries promised to donate nearly 190 million vaccine doses to WHO, with the first doses of the donated vaccines to be distributed in Azerbaijan, Mongolia and Afghanistan next month. However she admitted she had not yet had a vaccine but said she would have it soon.

She said that although countries are now better prepared to cope with a global disease outbreak, people still had to be aware of the dangers of bird flu (H5N1).

She said this was more toxic and deadly than swine flu and that many countries remained ill-prepared for mass outbreaks of this virus.

“The world is not ready for a pandemic to be caused by H5N1,” she said.

Share and Enjoy:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • StumbleUpon
  • Twitter
  • Yahoo! Buzz
  • PDF
  • LinkedIn
  • Live
  • NewsVine
Medical sales reps work alongside doctors, even in operating rooms

Conflicts of Interest, Medical Cartel, Top Stories, Undue Influence

Medical sales reps work alongside doctors, even in operating rooms

1 Comment 27 December 2009

By David S. Hilzenrath

Washington Post
Sunday, December 27, 2009

(vactruth.com editor’s note: Here is a perfect example of how big companies influence the medical profession)

In a Florida operating room, a senior citizen with a collapsed vertebra lies face down and unconscious on the operating table, surrounded by members of a medical team.

If all goes well, they’ll insert a tiny inflatable balloon into the brittle bone and then stabilize it by injecting cement. It’s a delicate procedure that deploys needles close to the spinal cord, and it takes a coordinated effort.

There’s an anesthesiologist alternating with a nurse anesthetist, an X-ray technician and a circulating nurse; there’s a pair of scrub techs to handle surgical instruments; there’s the surgeon, a middle-aged orthopedist who has never performed this type of operation before.

And, at the foot of the operating table, there’s Chuck Bates, a guy who studied biology in college and always wanted to go to medical school but never did.

Instead, he began his career selling hot dogs to grocery stores.

As the surgeon prepares to make an incision, Bates stares at the X-ray monitor.

Come up one centimeter and make your incision there, Bates tells the surgeon.

A little later, when it appears that the doctor is going to use his hand to push a needle into the patient’s spine, Bates suggests that he try a mallet instead.

Just tap-tap-tap, Bates advises.

The job wholesaling hot dogs enabled Bates to get an MBA on the weekends, and then a friend told him about a career more in tune with his interests, which led to employment with Kyphon, a manufacturer of medical devices.

Devices used to repair fractured vertebrae.

That’s how Charles E. Bates III came to be standing at a patient’s feet several years ago, doing his part to advance a new procedure called kyphoplasty.

Bates was the salesman in the operating room.

Although patients may not be aware of their presence, sales representatives have become fixtures in operating rooms across America. They come bearing artificial hips and artificial knees, cardiac pacemakers and implantable defibrillators, spinal stabilizers and mesh used to support prolapsed bladders. They deliver screws to hold bones together, and protein substances meant to make bone grow again.

At a time when Washington is trying to find new economies in health care, salesmen in the operating room serve as simple reminders that medicine is a business, with all the potential that entails to promote efficiency, boost sales and extract profit.

But should they be there at all?

In an age of rapidly proliferating technologies, the salesmen may know more about their products than the doctors who use them do.

In an environment where data is often lacking about the relative effectiveness of one product vs. another, or even about the merits of doing a procedure such as kyphoplasty at all, sales reps can tip the balance.

In the business that is surgery, they deliver devices to hospitals as needed, and they make sure the scrub techs know precisely which instruments and components the surgeon will reach for next. They speed procedures along, making time for more.

“They are critical to the efficient execution of hip and knee replacements,” said Denver orthopedist Ted Parks.

Many medical devices could not be used — or used safely — without sales reps, said David Nexon, senior executive vice president of the Advanced Medical Technology Association, an industry group.

Richmond gynecologist Catherine A. Matthews said that’s a frightening argument.

“They’re not in any way motivated to recommend what might be the best thing for the patient,” Matthews said. “They’re there to sell their product.”

Doctors shouldn’t have to depend on reps for expertise, she added.

The legislation being crafted on Capitol Hill could nudge the nation’s medical system toward new ways of doing business — making doctors more sensitive to costs, giving patients more information about what works and what doesn’t, paying hospitals based on the quality of their outcomes.

In short, it might begin to weaken the influence of the doctor-salesman relationship.

In the meantime, sales reps fill a vacuum.

Vince Proffitt knows the business well. He sells spinal implants in the Washington area, and he’s on call 24-7. If someone’s been in a car wreck, he says, timely delivery is about more than just efficiency.

The best part of the job, the father of two said, is “the fact that I can actually make a difference and help people.”

He’s talking about the patient lying “pretty helpless on that table,” but he says he’s also there for the doctor. “Any surgeon likes to have his team. And I think what we try to do is become a part of that surgical team.”

A former U.S. Air Force intelligence officer, Proffitt said he preps medical teams with attention to detail, “much like I would prepare an air crew for their mission.”

He used to work for the big manufacturer Medtronic, where he was successful enough to make the President’s Club, earning a trip to Hawaii. Now he runs his own medical device distribution firm, Spartan Medical.

On LinkedIn, he made it clear that he means business.

“My goal is to build, train, and coach a team of hard-charging professionals to gain market domination,” Proffitt said in an online profile. “Our team hunts in packs, takes care of each other . . . and believes victory is the only option.”

The key to success, Jim Rogers says, is a technique he calls “Dynamic Psychological Selling.”

An enthusiastic talker with a gleaming smile, Rogers used to be a sales executive for Wright Medical Technology, a major manufacturer of surgical implants. Then last year he founded the American Institute of Medical Sales, whose mission is training people to be salesmen in operating rooms.

The curriculum at the institute ranges from how to perform a joint replacement to how to get inside a surgical suite without an invitation.

“Excuses to use to be in a hospital without a case,” an institute brochure says.

Using hours of videotaped role-playing, Rogers teaches would-be salesmen the art of engaging surgeons in conversation. Conversations lead to relationships, which lead to sales.

Rogers coaches students to research doctors’ medical writings and hobbies, so they can break the ice with a line like this: “By the way, I read your paper on ACL reconstruction in teens. Fantastic article!”

The idea is to sell without making the surgeon feel that he’s being sold.

“If you have a good relationship with a surgeon and you can convince the surgeon to use your product, that surgeon can then convince the hospital to use your product,” Rogers said.

To win surgeons over, sales reps must demonstrate that they can save time in the operating room, Rogers says.

“A surgeon is driven on how many cases can you do in one day. They want to be able to do as many cases as they can.”

To give aspiring reps a feel for surgery, the institute used to train them on cadaver parts, but that got expensive; now students work on anatomical models called sawbones. The institute also takes trainees into operating rooms to observe surgeons and reps in action. One of Rogers’s goals is to weed out the squeamish: Some people faint at the sight of blood.

Since it opened, the institute, which also runs a recruitment service, has received 46,000 résumés, Rogers said. All sorts of people are clamoring to get into the business, he explains. Real estate agents, stockbrokers, insurance salesmen. People who have sold copiers, software and uniforms. “It’s easily the hottest industry, bar none,” Rogers said. “There are sales reps in our business that make over $1 million a year.”

(The average for those who’ve been at it for at least three years is $150,000, based entirely on commissions, Rogers said.)

Now the institute is planning a new program — a television program. The title for the proposed reality show:

“Sell O.R. Go Home.”

The presence of the salesman in the operating room has long raised concerns that it can put the interests of manufacturers before those of patients.

The issue was brought sharply into focus in 2003, when Endovascular Technologies pleaded guilty to federal charges that it covered up malfunctions of a device used to treat aortic aneurysms.

The government alleged that sales representatives were part of the coverup.

When the device became stuck in patients’ bodies during surgery, sales representatives coached doctors in an unapproved technique to remove the device by breaking it, the government alleged. Use of that approach, which a sales representative helped develop, kept malfunctions below the radar of the Food and Drug Administration, the government said.

A dozen patients died from malfunctions, and many others had to undergo more invasive surgery, the government said.

A history of controversy surrounding medical device marketing may help explain why some companies want nothing to do with a story about sales reps in the operating room.

“I would hope that you would not mention Boston Scientific in your story,” a spokesman for that company e-mailed.

Major device makers such as Johnson & Johnson, Stryker and Zimmer declined to arrange interviews for this article.

In a statement, Medtronic spokesman Charles Grothaus said that “most surgeons who use medical devices in their procedures expect a technical field rep to be present during the procedure, because they understand that the rep’s special product expertise enhances patient safety.”

“Actual medical decisions and selection of components are left up to the operating surgeon, who uses the technical representative as a real time resource in making those decisions,” Grothaus said.

Chuck Bates worked as a salesman and regional sales manger for Kyphon from 2001 to 2005. His first task, he said, was getting doctors interested in Kyphon’s procedure. Once they were interested, Kyphon would give them one-day courses in which they practiced on cadavers. Other surgeons would lead the class, but “the hands-on training was done mostly by the sales reps,” Bates said.

After bonding over that experience, some reps became so close with physicians that they stayed with them as houseguests, Bates said.

Kyphoplasty, the procedure Bates and his colleagues were promoting, competed with an older approach known as vertebroplasty. Both could be used on patients with osteoporosis, a deterioration of the bone. A key difference was that kyphoplasty employed the Kyphon balloon tamp.

Then there was the price: Kyphoplasty was much more expensive.

A 2004 article in the American Journal of Neuroradiology said that both procedures had benefits but that additional trials were needed to determine their relative effectiveness. Meanwhile, the FDA warned of potentially dangerous complications.

Bates said that he promoted kyphoplasty as a way for doctors to increase their incomes and help their patients.

A 2003 document containing internal comments from the Kyphon sales force — which was later used in litigation — shed light on other reps’ agendas.

“Nora and I have developed a strong personal friendship with Dr. Graham and his wife. We meet at least once every three weeks for dinner, etc. Result — 21 levels in April,” one representative wrote, apparently referring to the number of vertebrae on which the doctor had operated. “My goal is to have the surgeon treat and the [primary-care physician] refer cases as much for me personally as for the patient,” the sales rep added.

A second sales rep reported that he was trying to persuade surgeons to operate on more vertebrae per case.

“My one problem is that all of my surgeons except one are doing only one level on each patient. This has kept me from reaching my goal of 100k per month,” the rep wrote.

A third rep spelled out a strategy to get patients into surgery sooner. The trouble, as that rep described it, was that operations were getting postponed “and eventually the patient’s symptoms subside which translates into a cancelled case.”

Why would surgery be warranted for anyone whose symptoms went away?

Their fractures might worsen, former Kyphon reps said.

Bates said in an interview that he helped solicit business for his surgeons by donning scrubs and going to the offices of potential referring physicians.

At the company’s urging, he and other Kyphon reps taught doctors and hospitals how to maximize the money the federal Medicare program would pay, Bates said.

Although the minimally invasive procedure could ordinarily be performed on an outpatient basis, Kyphon reps recommended that patients be admitted overnight to elicit higher federal reimbursements, he said.

“The good sales reps would always make sure the physician had admitted the patient,” Bates said.

With the overnight stay, hospitals could profit from the procedure, Bates said. “The last thing you wanted to do was have them lose money and then stop doing kyphoplasty,” he said.

In 2004, Bates had a change of heart. As he recalled, he heard that hospitals in Texas were increasingly uncomfortable billing for kyphoplasty as an inpatient procedure, and the result was a decline in Kyphon’s business there. “We were afraid it was going to become a nationwide thing,” he said.

Ultimately, Bates concluded that “what we were doing was wrong,” he said, and he prepared to throw away his career.

He found his way to the Washington law firm Phillips & Cohen, which specializes in representing whistleblowers. While it was reviewing Bates’s allegations, the firm heard independently from Craig Patrick, a former reimbursement manager at Kyphon who told a similar story, lawyer Mary Louise Cohen said.

In 2005, Bates and Patrick filed a whistleblower suit against Kyphon, alleging that the company was responsible for false or fraudulent Medicare claims.

Eric Roux, a former Kyphon sales manager, said he shook his head in disbelief when he heard about the lawsuit. “From the top on down, we were never, ever told to do anything inappropriate,” Roux said. “I know the good that we did.”

Kyphon denied any wrongdoing but last year agreed to pay the government $75 million. As their reward, the two whistleblowers and their attorneys shared $14.9 million.

By the time Kyphon settled the case in May 2008, it had been bought by Medtronic for $3.9 billion. Asked to address the allegations in Bates’s lawsuit, a Medtronic spokesman did not respond.

In a news release announcing the acquisition of Kyphon, Medtronic Chairman Art Collins looked toward a bright future.

As he put it: “Kyphon’s world-class, global sales force will play a central role in the continued development of our spinal business.”

Share and Enjoy:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • StumbleUpon
  • Twitter
  • Yahoo! Buzz
  • PDF
  • LinkedIn
  • Live
  • NewsVine
EXPLOSIVE CONFLICT OF INTEREST: WHO PROFITS FROM THE NATIONAL HEALTH PLAN? AND FROM OTHER INVESTMENTS…

Conflicts of Interest, Jon Rappoport, Medical Cartel, Top Stories, Undue Influence

EXPLOSIVE CONFLICT OF INTEREST: WHO PROFITS FROM THE NATIONAL HEALTH PLAN? AND FROM OTHER INVESTMENTS…

1 Comment 26 December 2009

.
.
Source:
www.insolutions.info S.

By Jon Rappoport
www.insolutions.info
www.nomorefakenews.com
DECEMBER 25, 2009.

I have to begin by saying you need to know about Walter Burien.  http://CAFR1.com

Walter curls people’s hair.  For many years, he has been investigating the investments made by governments.  The what?  I know.  This sounds like a non-sequitur.  Governments aren’t businesses, are they?

It turns out they are.  Well, when you think about it, it’s obvious.  They run, for example, retirement funds for their employees, and those funds make investments, they don’t just store money in shoe boxes.

Recently, Walter provided a link to the New York State Retirement Fund Asset Listing (March 31, 2006).  You can find it at: http://cafr1.com/STATES/NEWYORK/RETIREMENT/NYRINV2006.PDF

This document shows the investments this fund makes, and the value of each stock holding.  The implications are enormous.  For example, when you pinpoint the many pharmaceutical stocks, you realize New York State government will be a primary beneficiary of any national health plan.  Why?  Because drug companies, under such a plan, will be selling far more drugs as millions of new, previously uninsured people come under the federal umbrella.

Any piece of news that makes the pharma landscape glow tends to shoot up stock values.

From a financial point of view, it would be ridiculous to assume New York State government would oppose national health insurance.  It’s good for business.  The business of, yes, New York State government.

And by the way, to the extent that some of these drug companies manufacture vaccines (and they do), the New York State government would be a big-time supporter of the mass vaccinations that accompany each new phony epidemic, such as Swine Flu.  Again, for business reasons.  In fact, we may now understand a new reason why, until huge protests derailed it, New York tried to make the H1N1 vaccine mandatory for all state health workers.

Here are some of the pharmaceutical listings in the New York Retirement Fund.  The value of each stock holding is as of Mar.31, 2006.

Schering-Plough: $138,013,129
Barr: $39,152, 525
Baxter: $105,606, 745
Gilead: $127,348,101
Roche: $87,762,875
MedImmune: $46,942, 968
Sanofi-Aventis:$153,887,891
Bayer: $39,318,918
Bristol-Myers Squibb: $195,807,422
GlaxoSmithKline: $137,729,350
Pfizer: $834,756,329
Novartis: $131,221,033
Merck: $344,768,742
Eli Lilly: $249,409,636
Vertex: $17,947,395

Drug companies.  $2.5 billion and change.  One retirement fund in one state.

Walter Burien goes much further—and here you would have to consult his site for supporting evidence.  He states that, when you look at the various investment funds of the 50 state governments, and when you consider the possibility that many of these funds act (invest) in concert, governments turn out to be controlling stockholders in some of the biggest corporations in America.

Turn that thought over in your mind a few times.

Here’s another explosion:  To what degree did the federal bailout bail out the New York State government?  Well, among the 2006 NY Retirement Fund listings, we have:

Goldman Sachs: $268,770,613
Bank of America: $896,993,638
Citigroup: $1,036,682,080.

This gives another perspective on what a fed bailout means.  It functions as profit protection.  For a state government.

Imagine state legislators and other state officials consulting THE INVESTMENT PORTFOLIO of their state government before they vote for or against legislation.

The hits keep coming.

“As governor of your state, my friends, I am taking every action I can to assure the profits of this administration continue to rise.  As taxpayers, you are the stakeholders.  What you pay us, we invest.  Of course, we never show you the balance sheet, and we never indicate whether we need your taxes, or whether our profits alone are sufficient for running the state.  But that’s the way the game works.  You stay in the dark.  When we raise your taxes, we give you reasons—which may be accurate or sheer nonsense.  The point is, we keep taking your money and investing it…”

JON RAPPOPORT
www.insolutions.info
www.nomorefakenews.com

Share and Enjoy:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • StumbleUpon
  • Twitter
  • Yahoo! Buzz
  • PDF
  • LinkedIn
  • Live
  • NewsVine
Advisers on Vaccines Often Have Conflicts, Report Says

Conflicts of Interest, Medical Cartel, Top Stories, Undue Influence, Vaccine Development

Advisers on Vaccines Often Have Conflicts, Report Says

No Comments 24 December 2009

GARDINER HARRIS
New York Times
December 18, 2009

WASHINGTON — A new report finds that the Centers for Disease Control and Prevention did a poor job of screening medical experts for financial conflicts when it hired them to advise the agency on vaccine safety, officials said Thursday.

Most of the experts who served on advisory panels in 2007 to evaluate vaccines for flu and cervical cancer had potential conflicts that were never resolved, the report said. Some were legally barred from considering the issues but did so anyway.

In the report, expected to be released Friday, Daniel R. Levinson, the inspector general of the Department of Health and Human Services, found that the centers failed nearly every time to ensure that the experts adequately filled out forms confirming they were not being paid by companies with an interest in their decisions.

The report found that 64 percent of the advisers had potential conflicts of interest that were never identified or were left unresolved by the centers. Thirteen percent failed to have an appropriate conflicts form on file at the agency at all, which should have barred their participation in the meetings entirely, Mr. Levinson found. And 3 percent voted on matters that ethics officers had already barred them from considering.

The inspector general recommended that the centers do a far better job of screening. In a reply, the agency’s new director, Dr. Thomas R. Frieden, agreed.

“Since the period covered in this review, C.D.C. has strengthened the financial disclosures and conflict-of-interest process by instituting improved business processes and realigning responsibilities and oversight,” Dr. Frieden wrote.

As numerous medicines have been pulled from the market in recent years, worries have grown that experts may be recommending medical products — even ones they know to be unsafe — in part because manufacturers are paying them.

As a result, government agencies, medical societies and medical journals have become increasingly insistent that experts disclose potential conflicts. And while the experts invariably insist that they have done so, government audits routinely find large gaps between these disclosures and the experts’ actual income from consulting.

Congress tightened the rules on outside consulting after similar conflicts were found among members of advisory panels to the Food and Drug Administration. But little attention has been paid to the potential conflicts of advisers to the C.D.C., even though that agency’s committees have significant influence over what vaccines are sold in the United States, what tests are performed to detect cancer and how coal miners are protected.

Most of the advisers identified by Mr. Levinson had either a job or a grant from a company or other entity whose interests were affected by the committees’ discussions, and a considerable number also owned stock in such companies, the report said.

Representative Rosa DeLauro, a Connecticut Democrat who said she had long been a supporter of the C.D.C., said: “That is why I am so concerned about this report issued by the inspector general exposing serious ethics violations within the C.D.C. All members of the federal advisory committees, whose recommendations direct federal policy, should be without conflict of interest.”

Share and Enjoy:
  • Print
  • Digg
  • del.icio.us
  • Facebook
  • StumbleUpon
  • Twitter
  • Yahoo! Buzz
  • PDF
  • LinkedIn
  • Live
  • NewsVine

Newsletter

Click to Join Our Newsletter! Carl Bruning Constitutional Larimer County Sheriff

Users Online

Featured Vaccine Book

Dr. Todd Elsner's Book

 

Today, according to the CDC’s recommended vaccination schedule, a child receives 36 shots containing a total of 126 vaccines from birth through six years of age. This is quadruple the number of vaccines a child received in the 1980’s. In 1983 a child received only 10 shots containing 30 vaccines.

Could this quadrupling of the schedule be responsible for the drastic increase in childhood disorders we are seeing today?

 

Get the information your pediatrician will never tell you!

Live Healthy

Award Winning Inspirational Documentary by Valya Boutenko
Best Selling Books and DVDs from the Raw Family

Ads

Silver Lungs

Optimize Your Health

Vibrant Living with Delicious Green Smoothies